Hilderley Alicia J, Dunbar Mary, Andersen John, Fehlings Darcy, Metzler Megan, Carlson Helen L, Zewdie Ephrem, Hodge Jacquie, O'Grady Kathleen, Carsolio Lisa, Dlamini Nomazulu, Giuffre Adrianna, Cole Lauran, Kuo Hsing-Ching, Bourgeois Anna, Hollis Asha, Maiani Meghan, Ciechanski Patrick, Jadavji Zeanna, Craig Brandon, Kelly Dion, Keough Joanna, Wrightson James, Fay Linda, Switzer Lauren, Pajevic Maya, Ramsey Alana, Sametz Michael, Brooks Brian L, Yaskina Maryna, Batara Jesse, Hill Michael D, Kirton Adam
Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Alberta Children's Hospital Research Institute, Canada.
JAMA Neurol. 2025 Mar 1;82(3):267-275. doi: 10.1001/jamaneurol.2024.4898.
Current upper-extremity therapies provide inconsistent outcomes for children with unilateral cerebral palsy. Noninvasive brain stimulation, specifically transcranial direct current stimulation, may enhance motor gains when combined with therapy.
To determine whether the addition of neurostimulation to upper-extremity therapy enhances motor function in children with perinatal stroke and unilateral cerebral palsy.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter, randomized, sham-controlled phase 3 trial was conducted from July 2017 through March 2023. Investigators, treating therapists, outcome assessors, parents, and participants were blinded to intervention allocation. The study took place at 3 tertiary care Canadian pediatric rehabilitation hospitals. From a population-based sample of children 6 to 18 years old with perinatal stroke and disabling unilateral cerebral palsy, 196 children were approached and 107 were excluded.
Participants were randomly assigned in permuted blocks of 2 (1:1) to receive daily sham or cathodal stimulation to the contralesional motor cortex during 10 days of high-dose, child-centered intensive upper-extremity therapy.
The primary end points were changes from baseline to 6 months posttherapy in affected hand function and attainment of child-identified functional goals assessed by the Assisting Hand Assessment and Canadian Occupational Performance Measure. Safety was assessed, including any decrease in the function of either hand. Analysis was intention to treat.
Eighty-nine children were enrolled with 45 randomized to sham (62% male, 38% female; mean [SD] age, 10.7 [2.8] years) and 44 to stimulation (52% male, 48% female; mean [SD] age, 10.7 [2.1] years). Eighty-three participants had complete outcome data (42 sham, 41 stimulation). High proportions of children in both groups demonstrated significant functional gains sustained at 6 months (P < .001) with large effect size (Cohen d > 1). There were no differences between groups for mean (SD) change in hand function (5.2 [5.3] vs 4.6 [5.7]; P = .63) or goal attainment (3.0 [2.0] vs 3.6 [2.3]; P = .25). Procedures were safe and well tolerated with no serious adverse events.
In this study, results showed that patient-centered intensive motor learning programs could produce marked and sustained improvements in upper-extremity function in children with perinatal stroke and unilateral cerebral palsy. The addition of 1 milliampere contralesional motor cortex transcranial direct current stimulation did not improve outcomes compared with sham stimulation.
ClinicalTrials.gov Identifier: NCT03216837.
目前针对单侧脑瘫患儿的上肢治疗效果并不一致。非侵入性脑刺激,特别是经颅直流电刺激,与治疗相结合时可能会增强运动功能改善。
确定在上肢治疗中添加神经刺激是否能增强围产期卒中及单侧脑瘫患儿的运动功能。
设计、地点和参与者:这项多中心、随机、假对照3期试验于2017年7月至2023年3月进行。研究人员、治疗师、结果评估者、家长和参与者均对干预分配不知情。该研究在加拿大3家三级儿科康复医院开展。从6至18岁患有围产期卒中和致残性单侧脑瘫的儿童人群样本中,共接触了196名儿童,其中107名被排除。
参与者被随机分配到大小为2的置换区组(1:1),在为期10天的高剂量、以儿童为中心的强化上肢治疗期间,每天接受对侧运动皮层的假刺激或阴极刺激。
主要终点是治疗后6个月与基线相比患手功能的变化,以及通过辅助手评估和加拿大职业表现测量评估的儿童确定的功能目标的达成情况。评估了安全性,包括任何一只手的功能下降情况。分析采用意向性分析。
89名儿童入组,45名随机分配到假刺激组(男性62%,女性38%;平均[标准差]年龄,10.7[2.8]岁),44名分配到刺激组(男性52%,女性48%;平均[标准差]年龄,10.7[2.1]岁)。83名参与者有完整的结局数据(42名假刺激组,41名刺激组)。两组中很大比例的儿童在6个月时都表现出显著的功能改善且持续存在(P<0.001),效应量较大(科恩d>1)。两组在患手功能的平均(标准差)变化(5.2[5.3]对4.6[5.7];P = 0.63)或目标达成情况(3.0[2.0]对3.6[2.3];P = 0.25)方面没有差异。操作安全且耐受性良好,无严重不良事件。
在本研究中,结果表明以患者为中心的强化运动学习计划可使围产期卒中和单侧脑瘫患儿的上肢功能产生显著且持续的改善。与假刺激相比,添加1毫安对侧运动皮层经颅直流电刺激并未改善结局。
ClinicalTrials.gov标识符:NCT03216837。